Genesis Drug Discovery and Development (GD3), a member of the Genesis Biotechnology Group is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, ​and microbiome.

Therapeutics

Life Sciences

Biotechnology

Genesis Drug Discovery & Development (GD³)

Genesis Drug Discovery & Development (GD³)'s headquarters in Hamilton, United States

Description

People (5)

Anthony Rohr

Madeline Farley

James R. Beasley

Joyce Huang

William Solvibile

Jobs